ABI-112

N/A

Report date: 2024/07/26 15:43:53

Base Information

Drug NameABI-112
Drug Alias NameABI-112
ClassificationCell and gene therapy > Gene therapy > Viral vector-based gene therapy > Adeno-associated virus vector
Mechanisms of ActionGene transference
TargetsUpdating
Therapy Area/IndicationsDiabetic macular oedemaPolypoidal choroidal vasculopathyWet age-related macular degeneration
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAvirmax Biopharma Inc
China Registration ClassN/A

Develop Information

Active CompaniesAvirmax Biopharma Inc
Inactive CompaniesN/A
Active IndicationsDiabetic macular oedemaPolypoidal choroidal vasculopathyWet age-related macular degeneration
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A